NORTHBROOK, Ill., Oct. 2, 2025 /PRNewswire/ -- Endevica Bio, a clinical-stage biotechnology company pioneering peptide therapeutics for metabolic diseases, announced a major scientific breakthrough ...
Spurred by the discoveries of human pluripotent stem cell culture by James Thomson in the 1990s and the induction of pluripotency from adult cells by Shinya Yamanaka in the 2000s, therapeutics derived ...
Upstream Bio, Inc. raised approximately $293 million in an IPO, positioning it to leverage upstream pathway targeting of TSLP for treatment of patients with respiratory disorders using verekitug.
Pleasanton, CA, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Peak Bio, Inc. ("Peak Bio" or the "Company") (OTC PK: PKBO), is a clinical-stage biopharmaceutical company focused on developing the next-generation ...
OSSIO expands portfolio of highly differentiated bio-integrative fixation implants with small compression staples to enhance bunion repair patients’ satisfaction Revolutionary material science ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Asher Biotherapeutics (Asher Bio), a biotechnology company developing precisely-targeted immunotherapies for cancer, autoimmune, and infectious diseases, ...
NORTHBROOK, Ill., Oct. 2, 2025 /PRNewswire/ -- Endevica Bio, a clinical-stage biotechnology company pioneering peptide therapeutics for metabolic diseases, announced a major scientific breakthrough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback